In The News: January 2014

Postmenopausal Drug Approved by FDA Aids Osteoporosis in SomeThe Food and Drug Administration (FDA) has approved a novel estrogen-based drug for women to treat moderate-to-severe vasomotor symptoms associated with menopause as well as prevent postmenopausal osteoporosis. The new drug for menopausal women (Duavee) is the first to combine conjugated estrogens with bazedoxifene. Bazedoxifene is approved in Europe for the prevention of osteoporosis and has been shown to reduce the risk of endometrial hyperplasia, a possible…